Insider Selling: Beigene, Ltd. (NASDAQ:ONC) SVP Sells 1,202 Shares of Stock

Beigene, Ltd. (NASDAQ:ONC) SVP Chan Henry Lee sold 1,202 shares of the business’s stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $258.04, for a total value of $310,164.08. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Beigene Trading Up 7.5 %

Shares of NASDAQ ONC opened at $278.38 on Friday. The company has a quick ratio of 1.72, a current ratio of 1.93 and a debt-to-equity ratio of 0.05. The company has a market cap of $27.24 billion, a PE ratio of -33.78, a price-to-earnings-growth ratio of 7.73 and a beta of 0.63. Beigene, Ltd. has a 12 month low of $126.97 and a 12 month high of $287.88.

Beigene (NASDAQ:ONC) last announced its quarterly earnings results on Thursday, February 27th. The company reported ($1.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.88) by ($0.55). Beigene had a negative net margin of 25.94% and a negative return on equity of 25.12%. On average, equities analysts anticipate that Beigene, Ltd. will post -5.82 earnings per share for the current year.

Beigene Company Profile

BeiGene Ltd. Is a global oncology company, which engages in providing pharmaceutical products. Its medicines include BRUKINSA, TEVIMBRA, and PARTRUVIX. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in George Town, KY.